hVIVO plc (FRA:CRO)

Germany · Delayed Price · Currency is EUR

0.0975

-0.0025 (-2.50%)

Last updated: Feb 23, 2026, 8:11 AM CET

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Medical And scientific research services	66.22M	58.67M	50.70M	39.01M	-
Medical And scientific research services Growth	12.87%	15.72%	29.98%	-	-
Hvivo	-	-	-	-	14.34M
Venn	-	-	-	-	7.84M
Total	66.22M	58.67M	50.70M	39.01M	22.18M
Total Growth	12.87%	15.72%	29.98%	75.87%	-

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United Kingdom	2.28M	5.90M	-	-	-
United Kingdom Growth	-61.38%	-	-	-	-
Europe	17.39M	9.66M	-	-	-
Europe Growth	80.01%	-	-	-	-
North America	43.05M	40.48M	-	-	-
North America Growth	6.35%	-	-	-	-
Total	62.73M	56.04M	-	-	-
Total Growth	11.92%	-	-	-	-

Source: S&P Global Market Intelligence.